Should organisations prioritise workflow governance or model development first for healthcare AI?

Workflow governance should come first because it defines whether the AI can fit into real care delivery without creating friction or unsafe ambiguity. A strong model is of limited value if clinicians cannot trust the data path or decision context that feeds it.

Why workflow governance belongs before model development in healthcare AI

Healthcare AI succeeds or fails inside a clinical workflow, not in isolation. If the data path, escalation path, and decision handoff are unclear, even a strong model can create confusion, delay, or unsafe reliance. Workflow governance sets the operating boundaries first, so development effort is spent on a use case that clinicians can actually use and supervise.

The practical question is whether the system can fit the care process, documentation rules, approval chain, and exception handling that surround the decision. That means defining who sees the output, who can override it, what evidence must be present, and what happens when the model is uncertain. Without those decisions, model quality is hard to translate into safe care delivery.

What workflow governance has to settle before a model is worth building

Workflow governance should define the clinical decision context before anyone optimises the model. In healthcare, context includes the task boundary, the patient population, the source data that is trusted, the point where a human must intervene, and the record that proves the AI was used appropriately. This is where identity security programme design matters because the people, systems, and approvals around the workflow need clear ownership.

It also needs to settle how data enters and leaves the process. If clinicians have to copy outputs between systems, if the model depends on incomplete records, or if audit evidence is not retained, the workflow is already fragile. A deployment that cannot explain its input provenance or its downstream action chain is not ready for a clinical environment, even if the underlying model scores well in testing.

Good workflow governance makes the model’s job smaller and clearer. It separates assistive tasks from decision-making tasks, limits where automation can act without review, and forces explicit escalation for edge cases. That is the point at which model development becomes a bounded engineering problem rather than an open-ended operational risk.

Why model development still matters, but only after the operating model is defined

Model development matters once the workflow has been narrowed to a stable, measurable use case. At that stage, teams can choose the right training data, evaluation metrics, calibration target, and monitoring plan. The model can then be judged against the workflow it must serve, instead of being overfit to a lab benchmark that says little about care delivery.

For healthcare AI, that sequencing prevents a common failure mode: building for accuracy while ignoring adoption. A model that is technically strong but awkward to use often gets bypassed, second-guessed, or used inconsistently. A workflow-first approach lets teams design for interpretability, turnaround time, and escalation behaviour at the same time as performance.

This is also where governance and implementation meet. If the workflow requires human confirmation for certain outcomes, the model should be developed to support that boundary rather than blur it. When the design is clear, development can focus on reliability, calibration, and the specific failure cases that matter in practice. NIST AI Risk Management Framework is useful here because it reinforces that trustworthy AI depends on governance, mapping, measurement, and lifecycle controls, not model performance alone.

Risk and Threat Considerations

Healthcare AI creates material risk when a model is introduced before the workflow is defined, because ambiguous handoffs can turn assistance into unsafe automation. The main exposure is not only model error, but misuse of a correct output in the wrong clinical context, especially when responsibility, escalation, and documentation are unclear.

Failure mechanism: Teams optimise the model while leaving data provenance, clinician review, override rights, and exception handling unresolved, which allows the system to be used outside its intended decision boundary.

Impact: That can lead to delayed treatment, overreliance on model output, inconsistent clinical practice, and weak auditability when something goes wrong.

Practitioner Guidance

What to prioritise: Start with the smallest clinical workflow that has a clear owner, a measurable decision point, and an obvious human override. That gives you a safe boundary for evaluation before you spend heavily on training or fine-tuning.

What to verify: Confirm that the workflow has defined input sources, uncertainty handling, escalation criteria, and evidence retention. If any of those are informal, the deployment is not ready for model optimisation because the operational risk is still undefined.

Decision rule: If clinicians cannot explain when they should trust, review, or ignore the AI output, the problem is workflow design, not model quality. Fix the operating model first, then evaluate whether the model deserves production use.

Practitioner takeaway: In healthcare AI, the safest path is to make the workflow governable before you make the model powerful; otherwise, you may improve prediction while degrading care delivery.

Related resources from NHI Mgmt Group

• Should organisations prioritise external exposure or internal credential governance first?
• Should organisations prioritise tool scoping or skill governance first for AI agents?
• Should organisations prioritise least privilege or lifecycle governance first for AI agents?
• When should organisations prioritise governance over more AI pilots in healthcare?